Healthcare Services Industry Financials, Performance and Ratios
-
Industry Score
37.8 /100
Rank 60 out of 131 Industries -
Advance/Decline
35/17
-
No. of Companies52
-
Avg. Market Cap2,175
-
Price to Earning Ratio23.84
-
Price to Earning Growth Ratio2.31
-
Price to Book Ratio6.90
-
Return on Equity6.35
-
Return on Capital Employed-
-
Return on Assets1.30
-
Dividend yield 1 year %0.42 %
-
Net Profit Growth Annual YoY %-12.07 %
-
Net Profit Growth Qtr YoY %-8561.52 %
-
Net Profit Growth Qtr QoQ %-225.42 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare Services Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare Services Peer comparison
Compare all stocks in Healthcare Services industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilon Health Inc |
|
248.9
|
0.6
|
L
H
0.5
0.6
|
L
 1.7%
H
0.5
0.7
|
L
 -7.7%
H
0.3
0.7
|
L
 -13.0%
H
0.3
1.1
|
L
 -82.9%
H
0.3
6.1
|
L
 -97.5%
H
0.3
29.4
|
L
H
0.3
44.8
|
L
H
0.3
44.8
|
| Concord Medical Services (ADR) |
|
15.9
|
3.7
|
L
 -3.7%
H
3.7
3.8
|
L
 0.6%
H
3.4
3.8
|
L
 -3.4%
H
3.2
4.1
|
L
 -15.3%
H
3.2
5.7
|
L
 -15.1%
H
3.2
10.8
|
L
 -72.7%
H
3.2
26.7
|
L
 -87.7%
H
3.2
47
|
L
 -92.3%
H
3.2
58.9
|
| Ginkgo Bioworks Holdings Inc (Class A) |
|
409.3
|
6.6
|
L
 1.7%
H
6.3
6.7
|
L
 -2.1%
H
6.3
7.2
|
L
 -34.6%
H
6.3
10.4
|
L
 -29.7%
H
6.3
11.1
|
L
 -12.3%
H
5
17.6
|
L
 400.8%
H
0.2
17.6
|
L
H
0.2
17.6
|
L
H
0.2
17.6
|
| DaVita |
|
10,198.5
|
152.6
|
L
 1.2%
H
147.2
153.4
|
L
 -2.4%
H
147.2
159.4
|
L
 8.3%
H
136.2
159.4
|
L
 30.3%
H
101
159.4
|
L
 3.8%
H
101
159.4
|
L
 92.2%
H
71.5
179.6
|
L
 41.8%
H
65.3
179.6
|
L
 118.7%
H
43.4
179.6
|
| Enhabit Inc |
|
692.9
|
13.7
|
L
 0.4%
H
13.6
13.7
|
L
 0.4%
H
13.6
13.7
|
L
 22.7%
H
10.8
13.7
|
L
 46.1%
H
8.9
13.7
|
L
 60.1%
H
6.5
13.7
|
L
 -3.1%
H
6.5
14.6
|
L
H
6.5
25.3
|
L
H
6.5
25.3
|
| Encompass Health Corp |
|
10,862
|
108.6
|
L
 1.6%
H
104.5
108.8
|
L
 0.7%
H
104.5
109.7
|
L
 3.1%
H
103.7
115.2
|
L
 -2.9%
H
92.8
115.7
|
L
 9.4%
H
92.5
128.0
|
L
 99.4%
H
51.2
128.0
|
L
 68.1%
H
42.2
128.0
|
L
 284.8%
H
27.3
128.0
|
| Fresenius Medical Care AG & Co. KGaA (ADR) |
|
13,076.3
|
23.4
|
L
 2%
H
22.9
23.5
|
L
 -0.2%
H
22.7
23.6
|
L
 -2.8%
H
22.4
24.7
|
L
 2.5%
H
20.9
24.7
|
L
 -2.4%
H
20.9
30.5
|
L
 22.3%
H
16.4
30.5
|
L
 -32.5%
H
12.8
42.5
|
L
 -44.0%
H
12.8
57.9
|
| Hims & Hers Health Inc (Class A) |
|
5,051.1
|
22.2
|
L
 40.8%
H
21.0
23.5
|
L
 52.6%
H
14.3
23.5
|
L
 -3.7%
H
13.7
23.5
|
L
 -43.4%
H
13.7
40.7
|
L
 -38.3%
H
13.7
70.4
|
L
 124.3%
H
5.7
73.0
|
L
 70.9%
H
2.7
73.0
|
L
H
2.7
73.0
|
| Pediatrix Medical Grp Inc |
|
1,668.3
|
20.1
|
L
 1.8%
H
19.1
20.1
|
L
 1.3%
H
18.9
20.1
|
L
 -3.8%
H
17.2
22.1
|
L
 -6.8%
H
17.2
23.1
|
L
 37.3%
H
11.8
25.0
|
L
 33.4%
H
6.6
25.0
|
L
 -27.4%
H
6.6
35.7
|
L
 -69.1%
H
6.6
77.0
|
| Sonida Senior Living Inc |
|
691.3
|
36.8
|
L
 0.5%
H
35.8
37.2
|
L
 2.6%
H
35.0
37.6
|
L
 7.7%
H
33.0
37.6
|
L
 21.0%
H
29.7
37.6
|
L
 49.5%
H
19.3
37.6
|
L
 216.1%
H
6
37.6
|
L
 25.3%
H
6
55.2
|
L
 -84.9%
H
6
292.8
|
| Teladoc Health Inc |
|
940.6
|
5.3
|
L
 4.3%
H
5.0
5.3
|
L
 0.8%
H
4.9
5.3
|
L
 5.8%
H
4.4
5.5
|
L
 -29.9%
H
4.4
8.1
|
L
 -42.1%
H
4.4
9.8
|
L
 -79.1%
H
4.4
30.4
|
L
 -97.0%
H
4.4
206.2
|
L
 -55.8%
H
4.4
308
|
| U.S. Physical Therapy Inc |
|
1,218.4
|
80.6
|
L
 -0.6%
H
77.9
80.9
|
L
 -2.9%
H
77.9
84.7
|
L
 -5.9%
H
73.9
90.9
|
L
 6.9%
H
73.9
90.9
|
L
 -0.3%
H
62.8
93.5
|
L
 -16.1%
H
62.8
124.1
|
L
 -29.6%
H
62.8
131.5
|
L
 56.9%
H
45.1
148.5
|
| Acadia Healthcare Co Inc |
|
2,278.6
|
24.7
|
L
 -3.6%
H
24.1
25.1
|
L
 5.4%
H
21.7
25.8
|
L
 84.8%
H
12.9
25.8
|
L
 76.5%
H
11.4
25.8
|
L
 -19.2%
H
11.4
31.4
|
L
 -65.8%
H
11.4
87.8
|
L
 -56.5%
H
11.4
89.9
|
L
 -55.7%
H
11.1
89.9
|
| Addus HomeCare Corp |
|
1,904.8
|
102.9
|
L
 -0.3%
H
99.4
103.4
|
L
 -0.7%
H
99.4
106.5
|
L
 -2.9%
H
99.4
118.2
|
L
 -7.4%
H
99.4
118.2
|
L
 6.0%
H
89.0
124.4
|
L
 -0.1%
H
77.3
136.7
|
L
 6.9%
H
68.6
136.7
|
L
 427.5%
H
15.3
136.7
|
| Aveanna Healthcare Holdings Inc |
|
1,525.1
|
7.3
|
L
 1.0%
H
7
7.3
|
L
 -0.8%
H
7
7.5
|
L
 -7.0%
H
7
8.1
|
L
 -20.7%
H
7
9.8
|
L
 89.6%
H
3.7
10.3
|
L
 359.1%
H
0.9
10.3
|
L
H
0.7
13
|
L
H
0.7
13
|
| Azenta Inc |
|
1,065.4
|
23.1
|
L
 -4.8%
H
22.5
23.9
|
L
 -14.3%
H
22.5
26.6
|
L
 -19.5%
H
22.5
30.7
|
L
 -34.0%
H
22.5
41.7
|
L
 -47.1%
H
22.5
45.3
|
L
 -46.4%
H
22.5
69.2
|
L
 -68.9%
H
22.5
124.8
|
L
 134.3%
H
9.0
124.8
|
| Biodesix Inc |
|
154.3
|
19.4
|
L
 3.3%
H
18.1
19.7
|
L
 26.6%
H
14.2
19.7
|
L
 86.9%
H
9.8
19.7
|
L
 149.0%
H
5.3
19.7
|
L
 12.5%
H
3.4
19.7
|
L
 -42.6%
H
3.4
44.2
|
L
 -94.5%
H
3.4
509.8
|
L
H
3.4
639.8
|
| Burning Rock Biotech Ltd (ADR) |
|
242.0
|
22.5
|
L
 1.0%
H
21.8
23.0
|
L
 -13.0%
H
20.3
26.3
|
L
 -33.9%
H
20.3
34.3
|
L
 23.5%
H
15.6
41.7
|
L
 297.2%
H
2.2
41.7
|
L
 -22.5%
H
2.2
41.7
|
L
 -93.2%
H
2.2
386.4
|
L
H
2.2
397.5
|
| Celldex Therapeutics Inc |
|
2,045.6
|
30.7
|
L
 4.4%
H
29.2
31.9
|
L
 2.1%
H
28.6
31.9
|
L
 29.3%
H
22.5
31.9
|
L
 3.1%
H
22.3
31.9
|
L
 48.7%
H
14.4
31.9
|
L
 -32.6%
H
14.4
53.2
|
L
 17.3%
H
14.4
57.2
|
L
 -44.3%
H
1.5
77.0
|
| DocGo Inc |
|
65.5
|
0.7
|
L
H
0.6
0.7
|
L
 -6.9%
H
0.6
0.8
|
L
 -14.1%
H
0.6
0.8
|
L
 -33.7%
H
0.6
1.0
|
L
 -77.9%
H
0.6
3.1
|
L
 -92.5%
H
0.6
10.8
|
L
 -93.2%
H
0.6
11.9
|
L
H
0.6
11.9
|
| Dyadic Intl Inc, DE |
|
29.0
|
0.8
|
L
 3.9%
H
0.8
0.8
|
L
 2.6%
H
0.7
0.9
|
L
 -5.9%
H
0.7
0.9
|
L
 -19.2%
H
0.7
1.0
|
L
 -44.8%
H
0.7
1.6
|
L
 -54.0%
H
0.7
2.7
|
L
 -84.4%
H
0.7
8.8
|
L
 -48.1%
H
0.7
11.0
|
| Ensign Grp Inc |
|
12,201.9
|
210.0
|
L
 1.3%
H
203.9
210.8
|
L
 -2.0%
H
201.2
218
|
L
 6.2%
H
198
218
|
L
 19.7%
H
167.4
218
|
L
 61.1%
H
118.7
218
|
L
 136.9%
H
85.5
218
|
L
 152.2%
H
68.3
218
|
L
 958.3%
H
15.4
218
|
| Euda Health Holdings Ltd |
|
18.5
|
0.5
|
L
 -32.9%
H
0.5
0.8
|
L
 -50%
H
0.5
1.0
|
L
 -55.9%
H
0.5
1.3
|
L
 -83.4%
H
0.5
3.0
|
L
 -86.4%
H
0.5
4.3
|
L
 -66.9%
H
0.4
6.3
|
L
H
0.4
10.5
|
L
H
0.4
10.5
|
| Fulgent Genetics Inc |
|
464.7
|
14.9
|
L
 1.7%
H
14.4
15.2
|
L
 -2.9%
H
13.5
15.2
|
L
 -36.5%
H
13.5
24.9
|
L
 -46.6%
H
13.5
29.0
|
L
 -20.0%
H
13.5
31.0
|
L
 -52.6%
H
13.5
44.1
|
L
 -84.3%
H
13.5
122.9
|
L
H
2.9
189.9
|
| Guardant Health Inc |
|
11,962.7
|
91.2
|
L
H
88.3
92.1
|
L
 -2.9%
H
88.2
96.5
|
L
 -10.5%
H
88.2
113.8
|
L
 -12.5%
H
88.2
120.7
|
L
 131.9%
H
34.9
120.7
|
L
 215.8%
H
15.8
120.7
|
L
 -28.7%
H
15.8
169.4
|
L
H
15.8
181.1
|
| Intelligent Bio Soln Inc |
|
6.6
|
4.1
|
L
 1.0%
H
3.9
4.3
|
L
 -8.9%
H
3.9
4.8
|
L
 -34.2%
H
3.7
6.3
|
L
 -42.3%
H
3.7
24.9
|
L
 -83.1%
H
3.7
24.9
|
L
 -99.0%
H
3.7
492
|
L
 -100.0%
H
3.7
17376
|
L
H
3.7
34176
|
| Joint Corp |
|
126.1
|
8.5
|
L
 -2.5%
H
8.4
8.7
|
L
 -3.6%
H
8.1
9.0
|
L
 -12.8%
H
8.1
9.6
|
L
 -1.9%
H
8.1
10.7
|
L
 -22.8%
H
7.5
13.5
|
L
 -47.4%
H
7.3
19.4
|
L
 -80.7%
H
7.3
111.1
|
L
 109.9%
H
1.9
111.1
|
| LifeMD Inc |
|
150.2
|
3.1
|
L
 4%
H
2.9
3.2
|
L
 16.9%
H
2.6
3.2
|
L
 -0.6%
H
2.6
3.4
|
L
 -14.3%
H
2.6
4.4
|
L
 -33.2%
H
2.6
15.8
|
L
 75.3%
H
1.1
15.8
|
L
 -79.8%
H
1.1
22.0
|
L
 239.1%
H
0.4
33.0
|
| LifeStance Health Grp Inc |
|
2,645.0
|
6.9
|
L
 -0.3%
H
6.7
7.0
|
L
 -4.6%
H
6.7
7.4
|
L
 1.2%
H
6.6
8.1
|
L
 7.8%
H
6.3
8.1
|
L
 -9.0%
H
3.7
8.1
|
L
 23.4%
H
3.7
9.6
|
L
H
3.7
29.8
|
L
H
3.7
29.8
|
| Neogenomics Inc |
|
1,157.9
|
8.9
|
L
 -0.5%
H
8.6
9
|
L
 -9.3%
H
8.6
9.8
|
L
 -21.9%
H
8.6
11.8
|
L
 -23.8%
H
8.6
13.7
|
L
 -11.7%
H
4.7
13.7
|
L
 -50.5%
H
4.7
21.2
|
L
 -78.5%
H
4.7
54.7
|
L
 27.1%
H
4.7
61.6
|
| Nutex Health Inc |
|
697.4
|
98.6
|
L
 9.2%
H
86.8
99.8
|
L
 -10.7%
H
84.0
117.7
|
L
 -1.3%
H
84.0
120
|
L
 -45.5%
H
84.0
193.1
|
L
 120.8%
H
40.7
193.1
|
L
 -55.3%
H
0.6
222.8
|
L
 -80.1%
H
0.6
7920
|
L
 -98.1%
H
0.6
30000
|
| Option Care Health Inc - Registered Shares |
|
4,641.8
|
29.7
|
L
 -0.6%
H
28.7
29.8
|
L
 -8.6%
H
28.7
32.3
|
L
 -12.7%
H
28.7
36.5
|
L
 -3.0%
H
28.7
36.8
|
L
 -12.8%
H
24.2
36.8
|
L
 -7.8%
H
21.4
36.8
|
L
 59.3%
H
16.0
36.8
|
L
 213.0%
H
3.9
36.8
|
| Opko Health Inc |
|
918.5
|
1.2
|
L
 2.5%
H
1.2
1.2
|
L
 0.8%
H
1.2
1.3
|
L
 -2.4%
H
1.1
1.3
|
L
 -8.3%
H
1.1
1.4
|
L
 -36.3%
H
1.1
2.0
|
L
 7.1%
H
0.9
2.2
|
L
 -72.2%
H
0.9
5.3
|
L
 -87.9%
H
0.9
12.2
|
| Pennant Group Inc |
|
1,193.8
|
34.4
|
L
 2.3%
H
33.0
34.8
|
L
 2.2%
H
31.9
34.8
|
L
 13.5%
H
28.8
35
|
L
 19.5%
H
26.7
35
|
L
 55.1%
H
21.7
35
|
L
 156.4%
H
10.3
37.1
|
L
 -32.6%
H
8.7
58.2
|
L
H
6.2
69.6
|
| Precipio Inc |
|
44.9
|
25.7
|
L
 -3.3%
H
24.7
26.6
|
L
 6.5%
H
23.1
27
|
L
 27.9%
H
19.5
27
|
L
 3.2%
H
19.5
28.3
|
L
 270.7%
H
3.9
28.5
|
L
 86.7%
H
3.9
28.5
|
L
 -40.9%
H
3.9
183.6
|
L
 -99.6%
H
3.9
14308.2
|
| Personalis Inc |
|
724.6
|
8.2
|
L
 4.1%
H
7.5
8.2
|
L
 -9.9%
H
7.5
9.4
|
L
 1.2%
H
7.5
9.6
|
L
 -16.9%
H
7.3
11.5
|
L
 97.1%
H
2.8
11.5
|
L
 159.0%
H
0.9
11.5
|
L
 -62.9%
H
0.9
29.9
|
L
H
0.9
53.5
|
| Radnet Inc |
|
4,824.0
|
62.3
|
L
 2.7%
H
58.7
63.4
|
L
 -10.7%
H
58.7
75.5
|
L
 -10.0%
H
58.7
75.5
|
L
 -18.2%
H
58.7
81.2
|
L
 23.9%
H
45
85.8
|
L
 155.0%
H
22.7
93.7
|
L
 182.4%
H
12.0
93.7
|
L
 947.6%
H
4.7
93.7
|
| Sera Prognostics Inc (Class A) |
|
74.5
|
1.9
|
L
 -1.0%
H
1.9
2.1
|
L
 -15.7%
H
1.9
2.5
|
L
 -23.4%
H
1.9
2.8
|
L
 -36.7%
H
1.9
3.9
|
L
 -55.3%
H
1.4
4.4
|
L
 -50.9%
H
1.4
12.4
|
L
H
1.1
15.5
|
L
H
1.1
15.5
|
| Talkspace Inc |
|
848.2
|
5.1
|
L
 7.6%
H
5.1
5.2
|
L
 6.2%
H
4.6
5.2
|
L
 32.0%
H
3.7
5.2
|
L
 63.6%
H
3.1
5.2
|
L
 76.0%
H
2.2
5.2
|
L
 481.8%
H
0.6
5.2
|
L
 -49.5%
H
0.5
10.4
|
L
H
0.5
12.5
|
| Tenon Medical Inc |
|
8.8
|
0.8
|
L
 4.0%
H
0.8
0.8
|
L
 -9.2%
H
0.7
0.9
|
L
 17.9%
H
0.7
0.9
|
L
 -28.8%
H
0.6
1.2
|
L
 -39.2%
H
0.6
5.9
|
L
 -99.6%
H
0.6
212.8
|
L
H
0.6
4791.2
|
L
H
0.6
4791.2
|
| Oncology Institute Inc |
|
268.6
|
2.7
|
L
 -1.8%
H
2.6
2.8
|
L
 -5.5%
H
2.6
3.1
|
L
 4.6%
H
2.3
3.1
|
L
 -14.2%
H
2.3
4.5
|
L
 279.2%
H
0.6
4.9
|
L
 93.6%
H
0.1
4.9
|
L
H
0.1
12.7
|
L
H
0.1
12.7
|
| GeneDx Holdings Corp (Class A) |
|
2,768.1
|
94.5
|
L
 7.3%
H
85
95.4
|
L
 18.6%
H
68.6
95.4
|
L
 12.1%
H
68.6
97.3
|
L
 -40.9%
H
68.6
165.6
|
L
 -3.6%
H
55.2
170.9
|
L
 549.6%
H
1.2
170.9
|
L
 -81.0%
H
1.2
616.8
|
L
H
1.2
896.9
|
| Exagen Inc |
|
76.6
|
3.4
|
L
 2.7%
H
3.2
3.4
|
L
 -6.6%
H
3.0
3.8
|
L
 -3.7%
H
3.0
4
|
L
 -51.7%
H
3.0
7.3
|
L
 4.6%
H
2.8
12.2
|
L
 38.5%
H
1.3
12.2
|
L
 -83.5%
H
1.3
23.2
|
L
H
1.3
29.9
|
| BrightSpring Health Services Inc |
|
8,173.1
|
42.2
|
L
 1.8%
H
40
42.4
|
L
 1.9%
H
39.4
42.7
|
L
 6.4%
H
37.5
44.9
|
L
 22.3%
H
34.5
44.9
|
L
 141.6%
H
15.5
44.9
|
L
 366.1%
H
7.9
44.9
|
L
 366.1%
H
7.9
44.9
|
L
 366.1%
H
7.9
44.9
|
| BrightSpring Health Services Inc - Unit |
|
-
|
139.4
|
L
 1.4%
H
135.7
139.4
|
L
 1%
H
124.8
141.6
|
L
 5.1%
H
124.8
148.0
|
L
 15.6%
H
118.2
148.0
|
L
 66.8%
H
80.8
148.0
|
L
 66.8%
H
80.8
148.0
|
L
 66.8%
H
80.8
148.0
|
L
 66.8%
H
80.8
148.0
|
| Autonomix Medical Inc |
|
4.9
|
0.4
|
L
H
0.4
0.5
|
L
 -2.3%
H
0.4
0.5
|
L
 7.5%
H
0.4
0.5
|
L
 -47.6%
H
0.3
0.9
|
L
 -83.8%
H
0.3
2.8
|
L
H
0.3
152
|
L
H
0.3
152
|
L
H
0.3
152
|
| Auna S.A. - Ordinary Shares - Cls A |
|
353.0
|
4.8
|
L
 -1.2%
H
4.5
4.8
|
L
 -10.7%
H
4.5
5.4
|
L
 0.2%
H
4.5
5.5
|
L
 -0.4%
H
4.5
5.7
|
L
 -31.4%
H
4.5
7.2
|
L
 -31.4%
H
4.5
7.2
|
L
 -31.4%
H
4.5
7.2
|
L
 -31.4%
H
4.5
7.2
|
| BrightSpring Health Services Inc - Unit |
|
-
|
139.4
|
L
 1.4%
H
135.7
139.4
|
L
 1%
H
124.8
141.6
|
L
 5.1%
H
124.8
148.0
|
L
 15.6%
H
118.2
148.0
|
L
 63.3%
H
68.1
148.0
|
L
 63.2%
H
68.1
148.0
|
L
 63.2%
H
68.1
148.0
|
L
 63.2%
H
68.1
148.0
|
| Concentra Grp Holdings Parent Inc |
|
2,903.3
|
22.6
|
L
 -1.1%
H
22.1
22.7
|
L
 -5.8%
H
22.1
23.9
|
L
 -4.0%
H
22.1
24.7
|
L
 17.1%
H
19.1
24.7
|
L
 1.5%
H
18.5
24.7
|
L
H
18.5
24.8
|
L
H
18.5
24.8
|
L
H
18.5
24.8
|
| Radiopharm Theranostics Ltd (ADR) |
|
38.9
|
4.9
|
L
 -1%
H
4.7
5.0
|
L
 -1%
H
4.6
5.1
|
L
 -0.6%
H
4.6
5.6
|
L
 12.5%
H
3.6
16.3
|
L
 19.0%
H
3.6
16.3
|
L
 19.0%
H
3.6
16.3
|
L
 19.0%
H
3.6
16.3
|
L
 19.0%
H
3.6
16.3
|
| Basel Medical Grp Ltd |
|
11.1
|
0.6
|
L
H
0.5
0.6
|
L
 -1.7%
H
0.5
0.7
|
L
 -9.2%
H
0.5
0.7
|
L
 -35.9%
H
0.5
1.1
|
L
 -85.3%
H
0.5
9.4
|
L
H
0.5
9.4
|
L
H
0.5
9.4
|
L
H
0.5
9.4
|
| Lumexa Imaging Holdings Inc |
|
1,393.0
|
14.7
|
L
 -0.5%
H
14.2
15.2
|
L
 4.2%
H
13.9
16.3
|
L
 36.4%
H
11.4
16.4
|
L
 -20.5%
H
10.0
19.5
|
L
 -20.5%
H
10.0
19.5
|
L
 -20.5%
H
10.0
19.5
|
L
 -20.5%
H
10.0
19.5
|
L
 -20.5%
H
10.0
19.5
|